Cleveland Clinic Foundation; Hematology and Oncology

Cleveland, Ohio 44195

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Renal Cell Carcinoma

Studies at this site

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma — Stopped early
• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early